Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Inclusion Criteria:

Patient Usability Testing Inclusion Criteria:

History of a cancer diagnosis
At least 18 years of age
Male or Female
The ability to give informed consent in English or Spanish
Able to use and read a smartphone (iPhone or Android)
Has a smartphone (iPhone or Android)

Community Usability Testing Inclusion Criteria:

At least 18 years of age
Male or Female
The ability to give informed consent in English or Spanish
Able to use and read a smartphone (iPhone or Android)
Has a smartphone (iPhone or Android)

Focus Group and Interview Inclusion Criteria:

Completed chemotherapy treatment for stage I-III breast cancer.
Age 18 to 64 (inclusive)
Female
Paid employment (full time or part time) in the three months prior to diagnosis or at time of consent to MSK protocol #10-071 (PI: Blinder)
The ability to give informed consent in English or Spanish
Able to use and read a smartphone (iPhone or Android)
Has a smartphone (iPhone or Android)

For Cohort 2:

Participants was covered by Emergency Medicaid at the time of diagnosis and/or at any point during their treatment for breast cancer

RCT Inclusion Criteria:

Localized invasive breast cancer (not stage 0 or stage IV)

If electronic medical record does not specify stage and patient is undergoing (neo)adjuvant chemotherapy, assume stage is I, II or III
Planning to undergo or undergoing adjuvant or neoadjuvant chemotherapy
Age 18 to 64 (inclusive)
Female
Employment statue of (full time or part time) (those who are on disability leave/medical leave, and other unique employment circumstances at the PI's dicretion are eligible)
Language preference as English or Spanish
Able to use and read a smartphone or tablet (e.g. iPad, iPhone or Android)
Has access to a smartphone or tablet (e.g. iPad, iPhone or Android)

Exclusion Criteria:

RCT Exclusion Criteria:

Stage 0 breast cancer (DCIS only)
Stage IV (metastatic) breast cancer
Recurrence with metastases of breast cancer
Participants or family members who are participating in MSK IHCD studies related to social determinants of health